We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

GSK Blasts Appeal Bid In Pa. Paxil Venue Dispute

Law360, New York (January 8, 2014, 8:12 PM EST) -- GlaxoSmithKline LLC on Monday blasted a bid to have the Third Circuit decide whether the company could send a suit alleging antidepressant drug Paxil caused birth defects from state to federal...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.